| Literature DB >> 32143677 |
Isabella Tarissi De Jacobis1, Rosa Vona2, Elisabetta Straface3, Lucrezia Gambardella2, Giulia Ceglie1, Francesca de Gennaro1, Ilenia Pontini1, Anna Chiara Vittucci4, Alessandra Carè2, Camilla Cittadini2, Alberto Villani1, Donatella Pietraforte5.
Abstract
BACKGROUND: Respiratory syncytial virus (RSV) is the most common cause of bronchiolitis in the pediatric population worldwide and an important cause of death in developing countries. It has been demonstrated that the balance between oxidant and antioxidant systems is disrupted in children with bronchiolitis and that oxidative stress contributes to the pathogenesis of this disease. Platelets play an important role in antimicrobial host defenses and contribute to pulmonary vascular repair being either targets or source of reactive oxidizing species. The main purpose of this study was to assessing sex differences in clinical characteristics and platelets activation during RSV bronchiolitis in infancy.Entities:
Keywords: Bronchiolitis; Platelets; Reactive oxidizing species; Respiratory syncytial virus; Sex differences
Mesh:
Substances:
Year: 2020 PMID: 32143677 PMCID: PMC7059674 DOI: 10.1186/s13052-020-0792-x
Source DB: PubMed Journal: Ital J Pediatr ISSN: 1720-8424 Impact factor: 2.638
Mean characteristics of patients admitted from January to December 2017
| Boys ( | Girls ( | ||
|---|---|---|---|
| Age, months | 2.4 (1–10) | 3.3 (1–12) | ns |
| Hospitalization (days) | 5.13 (6–19) | 5.8 (1–19) | ns |
| Illness duration (days) | 10.5 (6–20) | 8.7 (3–19) | ns |
| CRP, mg/dL | 0.92 (range 0.46–6.28) | ||
| RSVB (% of patients) | 47% | ||
| RSVA (% of patients) | 11.6% | 16% | ns |
| Rhinovirus (% of patients) | 6.25% | 4% | ns |
| Metavirus | 9.8% | 7% | ns |
| Other viruses | 7.1% | ||
| Coinfections (% of patients) | 4.46% | 7% | ns |
| Complications of the disease | 12.5% | 11% | ns |
| Mild thrombocytosis | 78.3% | ||
| Severe thrombocytosis | 10% | ||
| Oxygen therapy (% of patients) | 42.86.% | 48% | ns |
| Cortisone therapy (% of patients) | 46.4% | ||
| Antibiotic therapy (% of patients) | 35.7% | 35% | ns |
| Aerosol therapy with 2 ml of 3% hypertonic solution (% of patients) | 62% | 54% | ns |
CRP C reactive protein, RSVA Respiratory syncytial virus A, RSVB Respiratory syncytial virus B
Characteristic of patients with moderate bronchiolitis
| Moderate bronchiolitis | |
|---|---|
| Respiratory rate | Increased |
| Respiratory effort | Tracheal tug Nasal Flare Moderate chest wall retraction |
| Oxygen saturations | Saturation 90–95% |
| Feeding | 50–75% of normal feeds |
| Apnoea | Brief episodes |
Fig. 1ROS production evaluation and platelet characteristics in patients with bronchiolitis (15 boys and 12 girls). a ROS levels measured in fresh whole blood by electron paramagnetic resonance. ##/°°p < 0.01 (Patients vs HCs). The measures were carried out in triplicate. Histograms showing the percentage of platelets positives to: b Annexin V; c P-selectin/CD62; d PAC-1. Measures carried out by flow cytometry. The values represent the percentage ± SD of positive cells. Statistical analysis was performed by one-way analysis of variance (ANOVA). # p < 0.05 (Boys patients vs Boys HC); ## p < 0.01(Boys patients vs Boys HC); °°p < 0.01 (Girls patients vs Girls HC); °°°p < 0.001 (Girls patients vs Girls HC); §p < 0.05 (Boys patients vs Girls patients); §§p < 0.01 (Boys patients vs Girls patients). On the right typical flow cytometric measures of a representative HC boy and a representative patient boy, and a representative HC girl and a representative patient girl. (Pt = patient; HC = control group)